3-(Piperidin-4-yl)benzo[d]isoxazole hydrochloride

Catalog No. :
ACKCLY052
CAS No. :
84163-22-4
Molecular Formula :
C12H15ClN2O
Molecular Weight :
238.72

IUPAC Name:3-(piperidin-4-yl)benzo[d]isoxazole hydrochloride

3-(Piperidin-4-yl)benzo[d]isoxazole hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$103.00Login to see priceIn stockIn stock
25g98%$489.00Login to see priceIn stockIn stock
100g98%$1897.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(Piperidin-4-yl)benzo[d]isoxazole hydrochloride
IUPAC Name3-(piperidin-4-yl)benzo[d]isoxazole hydrochloride
MDL No.MFCD27978162
Molecular FormulaC12H15ClN2O
Molecular Weight238.72
SMILES[H]Cl.C1(C2CCNCC2)=NOC3=CC=CC=C13
InChI KeyJVRIOVDBNNWSHA-UHFFFAOYSA-N
Synonym3-(4-Piperidinyl)-1,2-benzisoxazole Hydrochloride;3-(piperidin-4-yl)benzo[d]isoxazole chlorohydride;Iloperidone Impurity 4(HCl);3-(Piperidin-4-yl)benzo[d]isoxazole Hydrochloride;4-(1,2-Benzisoxazol-3-yl)piperidine Hydrochloride;3-(4-piperidyl)-1,2-benzoxazole Hydrochloride;Pipoxazole,HCl (3-(4-Piperidinyl)-1,2-benzisoxazole Hydrochloride);3-(4-Piperidinyl)-1,2-benzoxazole hydrochloride
CAS No.84163-22-4
PubChem CID13076437

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACKCLY052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKCLY052 route product structure diagram
    ACKCLY05284163-22-4 In Stock
Inquiry

2. ACKCLY052 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKCLY052 route product structure diagram
    ACKCLY05284163-22-4 In Stock
Inquiry

Comments (0)